المؤلفون: Greiner JW, Morillon II YM, Schlom J

المصدر: ImmunoTargets and Therapy, Vol Volume 10, Pp 155-169 (2021)

مصطلحات موضوعية: interleukin-12, nhs-il12, immunotherapy, cancer, immuno-oncology, review., Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

Relation: https://www.dovepress.com/nhs-il12-a-tumor-targeting-immunocytokine-peer-reviewed-fulltext-article-ITT; https://doaj.org/toc/2253-1556

URL الوصول: https://doaj.org/article/bb535402a14f4248b78e70712c9fb461

المؤلفون: Smalley Rumfield C; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Pellom ST; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Morillon Ii YM; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Schlom J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA schlomj@mail.nih.gov., Jochems C; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Jun; Vol. 8 (1).

نوع المنشور: Journal Article; Research Support, N.I.H., Intramural

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Vaccines/*immunology , Carcinoma/*therapy , Immune Checkpoint Inhibitors/*administration & dosage , Papillomavirus Infections/*therapy , Papillomavirus Vaccines/*immunology, Animals ; B7-H1 Antigen/antagonists & inhibitors ; B7-H1 Antigen/immunology ; CD8-Positive T-Lymphocytes/drug effects ; CD8-Positive T-Lymphocytes/immunology ; Cancer Vaccines/administration & dosage ; Carcinoma/immunology ; Carcinoma/pathology ; Carcinoma/virology ; Cell Line, Tumor/transplantation ; Disease Models, Animal ; Female ; Human papillomavirus 16/immunology ; Humans ; Immunoconjugates/administration & dosage ; Immunogenicity, Vaccine ; Immunoglobulin G/administration & dosage ; Immunotherapy, Active/methods ; Interleukin-12/administration & dosage ; Lymphocytes, Tumor-Infiltrating/drug effects ; Lymphocytes, Tumor-Infiltrating/immunology ; Mice ; Oncogene Proteins, Viral/immunology ; Papillomavirus E7 Proteins/immunology ; Papillomavirus Infections/immunology ; Papillomavirus Infections/pathology ; Papillomavirus Infections/virology ; Papillomavirus Vaccines/administration & dosage ; Recombinant Fusion Proteins/administration & dosage ; Repressor Proteins/immunology ; Tumor Microenvironment/drug effects ; Tumor Microenvironment/immunology ; Vaccines, Subunit/administration & dosage ; Vaccines, Subunit/immunology

المؤلفون: Schwartz AL; Laboratory of Pathology, National Cancer Institute, Building 10 Room 2S235, 10 Center Dr, Bethesda, MD, 20892, USA.; Morphiex Biotherapeutics, Boston, MA, USA., Nath PR; Laboratory of Pathology, National Cancer Institute, Building 10 Room 2S235, 10 Center Dr, Bethesda, MD, 20892, USA.; National Eye Institute, Bethesda, MD, USA., Allgauer M; Laboratory of Pathology, National Cancer Institute, Building 10 Room 2S235, 10 Center Dr, Bethesda, MD, 20892, USA., Lessey-Morillon EC; Laboratory of Pathology, National Cancer Institute, Building 10 Room 2S235, 10 Center Dr, Bethesda, MD, 20892, USA., Sipes JM; Laboratory of Pathology, National Cancer Institute, Building 10 Room 2S235, 10 Center Dr, Bethesda, MD, 20892, USA., Ridnour LA; Cancer Inflammation Program, National Cancer Institute, Bethesda, MD, USA., Morillon Ii YM; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, MD, USA., Yu Z; Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Restifo NP; Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Lyell Immunopharma, South San Francisco, CA, USA., Roberts DD; Laboratory of Pathology, National Cancer Institute, Building 10 Room 2S235, 10 Center Dr, Bethesda, MD, 20892, USA. droberts@mail.nih.gov.

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2019 Nov; Vol. 68 (11), pp. 1805-1817. Date of Electronic Publication: 2019 Oct 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: CD47 Antigen/*antagonists & inhibitors , CTLA-4 Antigen/*antagonists & inhibitors , Ipilimumab/*administration & dosage , Lymphocytes, Tumor-Infiltrating/*immunology , Melanoma, Experimental/*mortality , T-Lymphocytes, Cytotoxic/*immunology, Animals ; CD47 Antigen/genetics ; CD47 Antigen/immunology ; Combined Modality Therapy ; Humans ; Lymphocytes, Tumor-Infiltrating/drug effects ; Lymphocytes, Tumor-Infiltrating/radiation effects ; Melanoma, Experimental/immunology ; Melanoma, Experimental/pathology ; Melanoma, Experimental/therapy ; Mice ; Mice, Inbred C57BL ; Radiation Dosage ; Survival Rate ; T-Lymphocytes, Cytotoxic/drug effects ; T-Lymphocytes, Cytotoxic/radiation effects ; Tumor Cells, Cultured